Writing in the Global Health Corps “Fellows” blog, fellow Brian Ngwatu from Uganda argues for increased investment in the local pharmaceutical production industry in Africa, which boasts “11 percent of the world’s population and 25 percent of the global disease burden” but “only one percent share of the world’s pharmaceutical markets.” He notes “two thirds of the global value of pharmaceutical products is produced in five countries (U.S., Japan, France, Germany and the U.K.) where the global disease burden is negligible,” and writes, “I can’t help but think of the significant amounts of donor money flowing into the purchase of [antiretroviral drugs (ARVs)] and other essential medicines in sub-Saharan Africa that could be diverted into local pharmacy production instead of flowing to multinational corporations and Indian generic manufacturers” (8/9).